Zobrazeno 1 - 10
of 75
pro vyhledávání: '"W Kevin, Kelly"'
Autor:
Hyun Kim, Mohammed Alshalalfa, Jean Hoffman-Censits, Costas D. Lallas, Elai Davicioni, Jianqing Lin, Ruth Birbe, Nicholas Erho, Jonathan Lehrer, Hussam Al-Deen Ashab, Mandeep Takhar, Anders Olson, Lucia L.C. Lam, W. Kevin Kelly, Karen E. Knudsen, Chellappagounder Thangavel, Roland Seiler, Felix Y. Feng, Edward M. Schaeffer, Edouard J. Trabulsi, Leonard G. Gomella, Mark D. Hurwitz, Adam P. Dicker, Robert B. Den
Publikováno v:
Urology Case Reports, Vol 9, Iss C, Pp 51-54 (2016)
Management of men with prostate cancer is fraught with uncertainty as physicians and patients balance efficacy with potential toxicity and diminished quality of life. Utilization of genomics as a prognostic biomarker has improved the informed decisio
Externí odkaz:
https://doaj.org/article/2c717d6f09b1472dbede2f384ec7c8f2
Publikováno v:
The Canadian journal of urology. 29(6)
We report the case of a 61-year-old male with metastatic prostate cancer who presented with urinary retention secondary to subdermal penile and corpora cavernosa metastases with neuroendocrine transformation of his metastatic hormone sensitive prosta
Autor:
Stephen J. Savage, Mary Brophy, Mei Chiung Shih, Tomasz M. Beer, Ying Lu, Valerie McGuire, Vivian Markle, Yajie Wang, William J. Aronson, Mark Garzotto, Edward Uchio, Joseph W. Basler, Robert J. Ringer, Kelvin K. Lee, Patricia Sinnott, Daniel W. Lin, Unyime Nseyo, R. Bruce Montgomery, Matthew R. Cooperberg, Claire C. Yang, W. Kevin Kelly
Publikováno v:
European Urology. 77:563-572
Background The Veterans Affairs Cooperative Studies Program study #553 was designed to evaluate the efficacy of adjuvant chemotherapy added to the standard of care (SOC) for patients who are at high risk for relapse after prostatectomy. Objective To
Autor:
Edouard J. Trabulsi, Jianqing Lin, Jean H. Hoffman-Censits, Mark D. Hurwitz, Robert B. Den, Benjamin E. Leiby, W. Kevin Kelly, Timothy N. Showalter, Leonard G. Gomella, Jacob Greenspan, Costas D. Lallas, Adam P. Dicker
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Cabazitaxel has been demonstrated to improve the overall survival for men with metastatic castrate-resistant prostate cancer. The purpose of this study was to determine the maximum tolerated dose for concurrent cabazitaxel with androgen depri
Autor:
Grace L. Lu-Yao, Krupa Gandhi, Scott W. Keith, Ginah Nightingale, W. Kevin Kelly, Ralph Zinner, Andrew E. Chapman, Kristine Swartz, Nikita Nikita, Swapnil Sharma
Publikováno v:
J Geriatr Oncol
OBJECTIVES: Polypharmacy (≥5 concurrent medications) is common among older patients with cancer (48%−80%) and associated with increased frailty, morbidity, and mortality. This study examined the relationship between polypharmacy and inpatient hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ed4c2624e2536c282511e5c68a6ae5
https://europepmc.org/articles/PMC8261864/
https://europepmc.org/articles/PMC8261864/
Autor:
Elizabeth I. Heath, Young E. Whang, David B. Weiner, Li Liu, Scott T. Tagawa, Ronald Tutrone, Kimberly A. Kraynyak, Matthew P. Morrow, Mark L. Bagarazzi, Jean D. Boyer, Jocelyn Cheung, Trevor McMullan, Neal D. Shore, Heather H. Cheng, Samantha Rosencranz, W. Kevin Kelly, Jorge A. Garcia, Leonard Joseph Appleman, Brian Sacchetta, Jeffrey M. Skolnik, Albert Sylvester, Khamal Bhatt, Luke T. Nordquist
Publikováno v:
Mol Ther
The management of men with prostate cancer (PCa) with biochemical recurrence following local definitive therapy remains controversial. Early use of androgen deprivation therapy (ADT) leads to significant side effects. Developing an alternative, clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30964232a43867bec87a0d60324b0bd3
https://europepmc.org/articles/PMC7210698/
https://europepmc.org/articles/PMC7210698/
Autor:
Christopher J. Hoimes, W. Kevin Kelly
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 2 (2010)
Prostate cancer relies on signaling through the androgen receptor (AR) for maintenance and progression; and androgen-deprivation therapy remains a cornerstone of treatment for advanced prostate cancer. An effective clinical classification of prostate
Externí odkaz:
https://doaj.org/article/67abe75a9c3a4594a0eb303dec5bb6bb
Autor:
Jennifer Johnson, S. Poudel, Massimo Cristofanilli, Martin Gutierrez, J. Doudement, Gaurav Singal, Stefan C. Grant, C. Ellis, V.A. Miller, John Douglas Mcpherson, Aniko Szabo, Ben George, Lindsay Chan, Smitha Menon, Brian M. Alexander, W. Kevin Kelly, Davendra Sohal, Christopher J. Hoimes
Publikováno v:
Journal of Thoracic Oncology. 15:S29-S30
Autor:
Matthew B. Bloom, J.A. Marascio, Adam P. Dicker, Edouard J. Trabulsi, Bashar Dabbas, John L. Gore, Anne Calvaresi, Daniel E. Spratt, Whitney H. Beeler, Mark D. Hurwitz, Daniel W. Lin, W. Kevin Kelly, Elai Davicioni, Worlanyo Sosu Sedzorme, Tiffany Le, Robert B. Den, James L. Godwin, Mark Mann, Leonard G. Gomella, Peter A. McCue, Karen E. Knudsen, Costas D. Lallas, Jingbin Zhang, J Ryan Mark
Publikováno v:
Prostate Cancer and Prostatic Diseases
Background Genomic classifiers (GC) have been shown to improve risk stratification post prostatectomy. However, their clinical benefit has not been prospectively demonstrated. We sought to determine the impact of GC testing on postoperative managemen
Autor:
Lee Ponsky, Michael O. Koch, Clint Cary, Radhika Walling, Robert Abouassaly, Edouard J. Trabulsi, Hristos Z. Kaimakliotis, Costantine Albany, Jean H. Hoffman-Censits, Nabil Adra, Matthew M. Cooney, Joel Picus, J. Luke Godwin, Pingfu Fu, Ginu Xavier, W. Kevin Kelly, Mark D. Fleming, Ariel Ann Nelson, Christopher J. Hoimes
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:We sought to assess if pembrolizumab (pembro) improves the pathologic response rate in locally advanced urothelial carcinoma (UC) when combined with gemcitabine (G) and ...